Earnings Feed
Start Free
MERIT MEDICAL SYSTEMS INC·4

Mar 2, 2:00 PM ET

Smith Christian Adam 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 2, 2026

Research Summary

AI-generated summary of this filing

Updated

MERIT (MMSI) CCO Christian Smith Receives RSU Awards, Surrenders Shares

What Happened

  • Christian Adam Smith, Chief Commercial Officer of Merit Medical Systems, received three awards totaling 21,374 shares (granted as RSUs/performance shares) on 02/26/2026 (acquired at $0.00). He also surrendered 2,018 shares to cover payroll and income taxes, a disposition recorded at $78.02 per share for a total withholding of $157,444. The surrender was not an open-market sale.

Key Details

  • Transaction date: 2026-02-26; Form 4 filed 2026-03-02 (timely — within required reporting window).
  • Grants (code A): 8,203 RSUs; 6,409 RSUs; 6,762 performance-based shares — all reported as acquired at $0.00.
  • Tax withholding (code F): 2,018 shares surrendered at $78.02 each; total value $157,444; footnote confirms shares were surrendered for payroll/income taxes and were not sold in the open market (F5).
  • Shares owned after the transactions: not specified in the lines provided; filing references plan holdings as of 02/26/2026 (F1).
  • Notable footnotes:
    • RSUs: Each RSU is the contingent right to one share upon vesting (F2, F3).
    • Vesting: one grant vests in three equal annual installments (F2); another vests in two equal installments on the 2nd and 3rd anniversaries (F3).
    • One grant represents performance-stock units that vested after the Compensation Committee determined performance conditions were met (F4).
    • Other vesting/exercisability schedules referenced in the filing (F6, F7) describe typical option vesting schedules but do not change the above RSU/performance-share details.

Context

  • These were awards (A) — not open-market purchases — so they increase potential future ownership only as the RSUs/performance shares vest; awards at $0.00 reflect that these are compensation grants, not cash purchases.
  • The 2,018-share disposition was a tax-withholding action (F) to satisfy payroll/income taxes; no shares were sold on the market.
  • For retail investors, awards signal compensation alignment but are not the same signal as an insider buying stock with personal funds.

Insider Transaction Report

Form 4
Period: 2026-02-26
MERIT MEDICAL SYSTEMS INCMMSI
Smith Christian Adam
Chief Commercial Officer
Transactions
  • Award

    Common Stock, No Par Value

    [F2]
    2026-02-26+8,203→ 19,181 total
  • Award

    Common Stock, No Par Value

    [F3]
    2026-02-26+6,409→ 25,590 total
  • Award

    Common Stock, No Par Value

    [F4]
    2026-02-26+6,762→ 32,352 total
  • Tax Payment

    Common Stock, No Par Value

    [F5]
    2026-02-26$78.02/sh−2,018$157,444→ 30,334 total
Holdings

  • Common Stock, No Par Value

    [F1]
    (indirect: By 401(k))
    598

  • Non-qualified stock options (right to buy)

    [F6]
    Exercise: $70.50From: 2022-10-04Exp: 2028-10-04→ Common Stock (25,000 underlying)
    25,000

  • Non-qualified stock options (right to buy)

    [F7]
    Exercise: $73.95From: 2024-03-31Exp: 2030-03-31→ Common Stock (8,259 underlying)
    8,259
Footnotes (7)
  • [F1]Represents plan holdings as of 02/26/2026.
  • [F2]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
  • [F3]Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
  • [F4]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03/31/2023.
  • [F5]The Reporting Person surrendered 2,018 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.
  • [F6]Become exercisable in equal annual installments of 25% commencing on 10/4/2022.
  • [F7]Become exercisable in equal annual installments of 25% commencing on 3/31/2024.
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact|2026-03-02

Documents

2 files